Cytonics Corporation completes a $4.8 million financing campaign with approximately 900 new investors. This funding will support the development of CYT-108 for osteoarthritis treatment.
Amount Raised
$4.8 Million
Round Type
Seed
JupiterBiotechnologyDescription
Cytonics Corporation announced the completion of a $4.8 million financing campaign, adding about 900 new investors. The total capital raised to date is $47 million. This financing will support the continued development of CYT-108, an investigational drug for osteoarthritis. Cytonics aims to move forward with regulatory and clinical planning for Phase 1b/2a studies.
Don't miss Cytonics Corp's next move
Get an email the moment Cytonics Corp raises, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
Cytonics Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.